Loading candles…
NGL Fine-Chem Ltd, incorporated in 1981, operates as a manufacturer and exporter specializing in pharmaceuticals, intermediates, Active Pharmaceutical Ingredients (APIs), and finished dosage forms. The company serves both veterinary and human health sectors, with a predominant emphasis on animal health. It holds a significant position in the veterinary API market, deriving approximately 90% of its revenue from animal health products. NGL Fine-Chem Ltd employs deep backward integration, producing 95% of its raw materials in-house, which supports its cost competitiveness and quality control efforts. The company is engaged primarily in the pharmaceuticals, veterinary health, and human health industries.
| To consider and approve the financial results for the period ended Jun 30, 2025 |
| 1 Aug 2025 |
| Results - FY25 | To consider and approve the financial results for the period ended March 31, 2025 and dividend | 22 May 2025 |
Besseggen InfoTech LLP is a SEBI-registered stock broker (Reg. No. INZ000213450), member of NSE (90155 (Cash & F&O)) and BSE (6722 (Cash & F&O)). Investment in securities market are subject to market risks; read all related documents carefully before investing.